Defining Levels of Automated Chemical Design
Author:
Affiliation:
1. Relay Therapeutics, 399 Binney Street, Cambridge, Massachusetts 02139, United States
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c00334
Reference98 articles.
1. Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 2: a discussion of chemical and biological data
2. Rethinking drug design in the artificial intelligence era
3. Critical assessment of AI in drug discovery
4. Applications of machine learning in drug discovery and development
5. De novo molecular design and generative models
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. DrugGym: A testbed for the economics of autonomous drug discovery;2024-06-02
2. Utopia Point Bayesian Optimization Finds Condition-Dependent Selectivity for N-Methyl Pyrazole Condensation;Journal of the American Chemical Society;2024-05-28
3. Reinvent 4: Modern AI–driven generative molecule design;Journal of Cheminformatics;2024-02-21
4. Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities;Frontiers in Pharmacology;2024-02-07
5. Paving the road towards automated homogeneous catalyst design;ChemPlusChem;2024-01-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3